Key Points - The stock of Renle will be delisted on July 4, 2025 [1] - Hualing Steel has been acquired by Xintai Life Insurance with a shareholding ratio of 5% [1] - Vanke A has applied for a loan of up to 6.249 billion yuan from Shenzhen Metro Group [1] - ST Yazhen has completed stock trading verification and will resume trading tomorrow [1] - Aerospace Chuangxin has regained procurement qualifications for military material engineering services [1] - Shangwei New Materials' controlling shareholder is planning a major event, and the stock will remain suspended [1] - Changling Hydraulic's actual controller is planning a change of control, and the stock will be suspended from tomorrow [1] - China Merchants Bank has been approved to establish China Merchants Financial Asset Investment Co., with a registered capital of 15 billion yuan [1] - Liugang Co. has experienced a potential irrational speculation risk with its stock [1] Operating Performance - Brothers Technology expects a net profit increase of 325% to 431.25% year-on-year for the first half of the year [1] - Huayin Power anticipates a net profit increase of 175 million to 215 million yuan year-on-year for the first half [1] - Xutian Salt Industry expects a net profit decrease of 76.34% to 80.29% year-on-year for the first half [1] - Juguang Technology expects a net loss of 42 million to 54 million yuan for the first half [1] - Beibu Gulf Port reported a cargo throughput of 31.1158 million tons in June, a year-on-year increase of 2.56% [1] - China Nuclear Power generated 115.104 billion kWh of electricity in the first half, a year-on-year increase of 15.92% [1] - Changyuan Power completed a power generation of 16.715 billion kWh in the first half, a year-on-year decrease of 8.3% [1] - Poly Developments signed contracts worth 29.011 billion yuan in June, a year-on-year decrease of 30.95% [1] Shareholding Changes - Jingye Da's actual controller plans to reduce holdings by no more than 3% [1] - Deyi Cultural Creation's actual controller Wu Tifang plans to reduce holdings by no more than 3% [1] - Caifu Trend's actual controller and chairman plan to reduce holdings by no more than 3% [1] - Annuo Qi's actual controller plans to reduce holdings by no more than 2% [1] - Suotong Development's actual controller and concerted actors plan to reduce holdings by no more than 2.21% [1] - Dingsheng Co.'s controlling shareholder plans to reduce holdings by no more than 1.71% [1] - Weitang Industrial's controlling shareholder plans to reduce holdings by no more than 1.95% [1] - Jinlong Automobile's Fujian Investment Group plans to reduce holdings by no more than 1% [1] - Wanye Enterprises' Guosheng Capital plans to reduce holdings by no more than 0.2% [1] - Zhonggang Luonai's Guoxin Shuangbai No.1 plans to reduce holdings by no more than 0.5% [1] - Funeng Technology's Shenzhen Anyan Investment plans to reduce holdings by no more than 1% [1] - Ankang Technology's Shenzhen High-tech Investment plans to reduce holdings by no more than 3% [1] - Donglai Technology plans to reduce no more than 1.2048 million repurchased shares [1] - Qujiang Cultural Tourism's controlling shareholder's 12 million shares are set to be auctioned [1] - Hesheng Silicon Industry's controlling shareholder plans to exchange no more than 1% of shares for ETF shares [1] Contract Awards - Boshi Co. signed an outsourcing service contract worth 109 million yuan with Guangxi Petrochemical [1] - Zhongyou Engineering's subsidiary signed a contract worth 294 million USD for the Atavi GMP pipeline project with Total Energy [1] - China Electric Power Construction's subsidiary signed a mining transportation project contract worth approximately 5.063 billion yuan [1] Other Developments - Xingxin New Materials plans to invest in a project with an annual output of 153,000 tons of polyolefin amine series products [4] - Haishun New Materials plans to acquire Sirewen Company to expand the application of electronic film materials in the semiconductor field [4] - Wankai New Materials is undergoing production reduction and maintenance, which is expected to significantly impact overall operating performance [4] - Donghu High-tech is participating in the establishment of the Donggao Frontier Phase II Fund to improve the development model of the park operation sector [4] - Jiete Biological plans to participate in the establishment of an industrial fund primarily investing in early and mid-stage biopharmaceutical projects [4] Asset Sales - Nord Shares plans to sell 70% equity of its wholly-owned subsidiary Jiangsu Lianxin for 70 million yuan [5]

Suspension and Resumption of Trading - *ST Yazhen has completed the stock price verification and will resume trading [1] - Changling Hydraulic's actual controller is planning a major event, leading to stock suspension [1] - Shangwa New Materials' controlling shareholder is planning a major event, resulting in continued stock suspension [1] Investment Cooperation and Operational Status - Vanke A has applied for a loan of no more than 6.249 billion yuan from Shenzhen Metro Group [2] - Hualing Steel has been lifted by Xintai Life Insurance, with a shareholding ratio reaching 5% [2] - Aerospace Chenguang has restored its procurement qualifications for military material engineering services [2] - China Oil Engineering's subsidiary has won a 2.121 billion yuan project from Total Energy in Iraq [2] - Shengde Xintai has won a steel pipe procurement project from Shanghai Boiler Factory, with a bid amount of approximately 217 million yuan [2] - Xingxin New Materials plans to invest 800 million yuan to construct a project with an annual output of 153,000 tons of polyolefin and polyamine series products [2] - China Nuclear Power expects to generate 115.104 billion kilowatt-hours of electricity in the first half of 2025, a year-on-year increase of 15.92% [2] Performance Changes - Brothers Technology expects a net profit of 60 million to 70 million yuan for the first half of the year, a year-on-year increase of 325.00% to 431.25%, driven by rising prices of some vitamin products [3] - Huayin Power expects a net profit attributable to shareholders of 180 million to 220 million yuan for the half-year, an increase of 175 million to 215 million yuan compared to the same period last year [3] - Nuotai Bio expects a net profit of 300 million to 330 million yuan for the first half of 2025, a year-on-year increase of 32.06% to 45.27% [3] - Yude Development expects a net profit of 175 million to 225 million yuan for the first half of the year, compared to a loss of 32.9 million yuan in the same period last year, mainly due to the transfer of 1% equity in Langfu Company and the recognition of investment income of 240 million yuan from the fair value remeasurement of remaining equity [3]

[Current Period Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) Brother Technology anticipates substantial H1 2025 year-over-year performance growth, projecting net profit attributable to shareholders to increase by 325.00%-431.25% and non-recurring net profit by 413.66%-548.83% [Performance Forecast Period](index=1&type=section&id=1%E3%80%81%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%9C%9F%E9%97%B4) This section specifies the timeframe covered by the performance forecast - The performance forecast period is from January 1, 2025, to June 30, 2025[2](index=2&type=chunk) [Performance Forecast Details](index=1&type=section&id=2%E3%80%81%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) This section presents the key financial indicators for the H1 2025 performance forecast, including net profit and EPS Key Financial Indicators for H1 2025 Performance Forecast | Item | H1 2025 (Jan 1 - Jun 30) (million CNY) | Prior Period (million CNY) | Year-over-Year Change (%) | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | Profit: 60.00 - 75.00 | Profit: 14.12 | Increase: 325.00%-431.25% | | Net Profit Excluding Non-Recurring Items | Profit: 57.00 - 72.00 | Profit: 11.10 | Increase: 413.66%-548.83% | | Basic Earnings Per Share (CNY/share) | Profit: 0.056 - 0.071 | Profit: 0.0133 | - | [Communication with Accounting Firm](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8E%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%B2%9F%E9%80%9A%E6%83%85%E5%86%B5) The financial data in this performance forecast is preliminary and has not been audited by a certified public accounting firm - The financial data related to this performance forecast has not been audited by a certified public accountant[3](index=3&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) The company's year-over-year performance growth is primarily due to increased prices for certain vitamin products and reduced costs, leading to an overall gross margin improvement - Prices for some of the company's vitamin products increased year-over-year[4](index=4&type=chunk) - Costs for certain products decreased[4](index=4&type=chunk) - Overall gross margin improved during the reporting period[4](index=4&type=chunk) [Other Relevant Information](index=1&type=section&id=%E5%9B%9B%E3%80%81%E5%85%B6%E4%BB%96%E7%9B%B8%E5%85%B3%E8%AF%B4%E6%98%8E) This performance forecast contains preliminary financial data, with detailed figures to be disclosed in the H1 2025 report, and investors are advised to exercise caution - The data in this performance forecast represents preliminary calculations by the company's finance department[5](index=5&type=chunk) - Detailed financial data will be fully disclosed in the company's H1 2025 report[6](index=6&type=chunk) - Investors are urged to invest rationally and be aware of potential risks[6](index=6&type=chunk)

Group 1 - The company, Brother Technology, expects a net profit attributable to shareholders of 60 million to 75 million yuan for the first half of 2025, representing a year-on-year increase of 325% to 431.25% [1] - The growth in performance is primarily attributed to the increase in prices of certain vitamin products compared to the previous year, as well as a decrease in costs for some products, leading to an overall improvement in gross profit margin during the reporting period [1]

Group 1: Project Dynamics - As of June 23, 2025, there are 607 ongoing private placement projects, with 18 new projects added in the last two weeks, a decrease of 3 from the previous period[5] - The number of terminated projects decreased by 4 to 7, while the number of projects approved by the review committee fell by 8 to 2[5] - The average time from proposal to approval for non-simple procedures is approximately 528 days, an increase of 274 days from the previous period[16] Group 2: Fundraising Overview - Total fundraising in the last two weeks reached 287.21 billion yuan, a significant increase of 96602.56% driven by two projects exceeding 100 billion yuan[27] - The average benchmark discount rate for competitive bidding projects decreased by 8.83 percentage points to 11.17%[27] - The average market price discount rate for competitive bidding projects increased by 0.58 percentage points to 18.38%[27] Group 3: Unlocking Gains - Among the 6 competitive bidding projects that were unlocked, 4 had positive returns, with a positive return rate of 66.67%, down 33.33 percentage points from the previous period[40] - The average absolute return rate on the unlocking day for these projects was 7.02%, a decrease of 12.76 percentage points[40] - The average market price discount rate for these projects was 13.29%, down 3.69 percentage points from the previous period[41] Group 4: Pricing Project Performance - The two pricing projects unlocked had an average absolute return rate of -11.04%, a decline of 198.24 percentage points, with a success rate of 50%[47] - The average market price discount rate for these pricing projects was 7.39%, down 18.96 percentage points[49] - The average industry return during the "issue-unlock" period was -25.23%, a decrease of 55.25 percentage points[49] Group 5: Risk Factors - Risks include slower-than-expected review progress, fluctuations in secondary market stock prices, and changes in the competitive bidding market environment[51]

股票代码：002562 股票简称：兄弟科技 公告编号：2025-040 兄弟科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保的审议情况 三、《最高额保证合同》的主要内容 保证人：兄弟科技股份有限公司 债权人：中国农业银行股份有限公司彭泽县支行 债务人：江西兄弟医药有限公司 被担保的主债权及最高额：保证人自愿为债权人与债务人形成的债权提供担保，担保的 债权最高余额折合人民币（大写金额）叁仟陆佰万元整。 最高额担保债权的确定期间：2025 年 5 月 30 日起至 2026 年 5 月 29 日止 保证担保的范围：包括债务人在主合同项下应偿付的借款本金、利息、罚息、复利、违 约金、损害赔偿金、按《中华人民共和国民事诉讼法》有关规定确定由债务人和担保人承担 的迟延履行债务利息和迟延履行金、保全保险费以及诉讼（仲裁）费、律师费等债权人实现 债权的一切费用。 兄弟科技股份有限公司（以下简称"兄弟科技"或"公司"）于 2025 年 4 月 14 日召开第六 届董事会第十六次会议以及第六届监事会第十一次会议，于 2025 年 5 月 21 日召开公 ...

股票代码：002562 股票简称：兄弟科技 公告编号：2025-040 兄弟科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保的审议情况 兄弟科技股份有限公司（以下简称"兄弟科技"或"公司"）于 2025 年 4 月 14 日召开第六 届董事会第十六次会议以及第六届监事会第十一次会议，于 2025 年 5 月 21 日召开公司 2024 年度股东大会，会议审议通过了《关于公司提供借款、担保事项的议案》。同意公司为江苏 兄弟维生素有限公司提供总额不超过 4 亿元人民币（含）的连带责任担保，为江西兄弟医药 有限公司（以下简称"兄弟医药"）提供总额不超过 15 亿元人民币（含）的连带责任担保。 在上述额度范围内，公司董事会申请股东大会授权董事长或者总裁办理和签署相关担保事宜 及材料，有效期自公司 2024 年度股东大会审议通过之日起十二个月内。具体内容详见披露 于《证券时报》、巨潮资讯网（http://www.cninfo.com.cn）上的《关于公司提供借款、担保 事项的公告》（2025-025）、《关于 ...

Core Viewpoint - Brother Technology Co., Ltd. is planning to issue A-shares to specific investors to raise funds primarily for expanding its production capacity of iodinated contrast agents, specifically increasing the production capacity of iodinated raw materials from 100 tons to 700 tons, with a total investment of approximately 69 million yuan for the project [1][9]. Group 1: Financial Overview - The company reported revenues of 3.41 billion yuan, 2.82 billion yuan, and a loss in 2023 due to declining prices of chromium salt products, which affected both revenue and gross margin [1][2]. - The gross margin for the main business was 24.83%, 10.40%, and 14.63% over the reporting periods, indicating significant fluctuations influenced by market conditions and raw material prices [4][5]. Group 2: Investment and Project Details - The funds raised will be allocated to construction, equipment purchase, and installation, leading to increased fixed asset depreciation and intangible asset amortization, which will raise operational costs [1][3]. - The project aims to achieve an annual production capacity of 600 tons of iodinated raw materials, with the feasibility of the project assessed based on market demand and competition [1][6]. Group 3: Risks and Challenges - There are risks associated with the inability to absorb the new production capacity if market demand does not meet expectations, potentially leading to excess capacity and increased competition [1][2]. - The company faces uncertainties regarding the economic benefits of previous fundraising projects, particularly if market conditions or regulatory environments change adversely [2][3]. - The company must navigate the complexities of regulatory approvals for its iodinated contrast agents, which could impact market entry and expected returns [5][6]. Group 4: Share Structure and Ownership - As of December 31, 2024, the company's total share capital is 106,370.05 million yuan, with 34.05% held as restricted shares and 65.95% as unrestricted shares [14]. - The top ten shareholders collectively hold 47.58% of the shares, indicating a diverse ownership structure [14].

股票简称：兄弟科技 股票代码：002562 兄弟科技股份有限公司 （住所：浙江省海宁市周王庙镇联民村蔡家石桥 3 号） 2023 年度向特定对象发行 A 股股票 募集说明书 （注册稿） 保荐机构（主承销商） （住所：中国（上海）自由贸易试验区商城路 618 号） 二〇二五年五月 兄弟科技股份有限公司 2023 年度向特定对象发行 A 股股票募集说明书 声 明 本公司全体董事、监事、高级管理人员承诺募集说明书及其他信息披露资 料不存在任何虚假、误导性陈述或重大遗漏，并保证所披露信息的真实、准 确、完整。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保 证募集说明书中财务会计报告真实、完整。 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对申 请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行 人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任何与 之相反的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由 发行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自 行承担证券依法发行后因发行人经营与收 ...

关于申请向特定对象发行股票获得中国证监会同意注册批复的公告 股票代码：002562 股票简称：兄弟科技 公告编号：2025-039 兄弟科技股份有限公司 公司董事会将根据上述文件和相关法律、法规的要求及公司股东大会的授权，在规定期 限内办理本次向特定对象发行股票事宜，并根据进展情况及时履行信息披露义务。敬请广大 投资者注意投资风险。 特此公告。 兄弟科技股份有限公司 董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 兄弟科技股份有限公司（以下简称"公司"）于近日收到中国证券监督管理委员会出具的 《关于同意兄弟科技股份有限公司向特定对象发行股票注册的批复》（证监许可〔2025〕1174 号），批复文件内容如下： "一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案实施。 三、本批复自同意注册之日起12个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时报告深圳证 券交易所并按有关规定处理。" 2025年6月10日 1 ...